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Case report
Granulomatous diseases in a patient with cystic fibrosis
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Abstract
We report the case of an adult with Crohn’s disease and pulmonary sarcoidosis on the background of cystic fibrosis (CF).
There is a recognized association between Crohn’s colitis and CF, but cases of pulmonary sarcoidosis in CF are rare. There may
be a pathogenic link between the two granulomatous disorders and CF with chronic immune stimulation leading to hyperimmu-
noglobulinemia, circulating immune complexes and subsequent granuloma formation.
 2003 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Although there is an association between Crohn’s
disease and cystic fibrosis (CF), there are very few
reports of pulmonary sarcoidosis in CF. We present the
unique case of an adult patient who developed both
these granulomatous disorders on the background of CF
complicated by multiorgan involvement, pregnancy and
Burkholderia cepacia (B. cepacia) colonization.
2. Case report
The 31-year-old woman was homozygous delta F 508
and chronically colonized with Pseudomonas aeruginosa
(P. aeruginosa). Five of her eight siblings also had CF.
Extrapulmonary manifestations included sinusitis, dia-
betes and pancreatic insufficiency requiring standard
enzyme supplementation. She experienced multiple
adverse drug reactions including arthritis of small and
large joints with ciprofloxacin.
In 1992 she presented with persistent anorexia and
nausea. Gastroscopy revealed esophagitis and she com-
menced ranitidine. Symptoms persisted and by 1994 she
was experiencing frequent vomiting, weight loss and
right iliac fossa pain with a palpable mass. Symptoms
and signs were attributed to distal intestinal obstruction
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syndrome (DIOS) and she was treated with cisapride
and paraffin oil. After failing to improve mucosal
biopsies confirmed Crohn’s disease (Fig. 1). Initial
symptom control was achieved with intravenous corti-
costeroids, however, following relapse, mesalazine was
added to her regimen. She continued to lose weight and
in 1994 underwent an ileocolectomy. At surgery a
chronic abscess extending into the retroperitoneum, right
psoas and ureter was found. There was an ileocolic
fistula. She had an uneventful acute post-operative
course and put on 13 kg weight. Symptoms were
subsequently well controlled on mesalazine alone. She
had a term pregnancy in 1995 complicated only by
gestational diabetes. Lung function was well maintained
(FEV s2.05 L 74% predicted). A prominent left hilum1
was noted on chest radiograph post delivery.
In 1996 she was colonized with B. cepacia genomovar
III sensitive to ceftazidime and meropenem. She
remained well but serial chest radiographs showed per-
sistent left hilar prominence. Chest CT revealed hilar
and mediastinal lymphadenopathy and mediastinal node
biopsy showed epithelioid cell non-caseating granulomas
consistent with sarcoidosis (Fig. 2). The tissue was
negative for acid-fast bacilli and fungi on stains and in
culture. No B. cepacia was isolated either from the
nodal specimens or the bloodstream and the onset of
her hilar adenopathy preceded the isolation of B. cepacia
from her sputum. Although not diagnostic, her serum
angiotensin converting enzyme (ACE) was elevated,
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Fig. 1. Pathology from the terminal ileum showing a deep-fissured
ulcer and erosion of the epithelial mucosa consistent with Crohn’s
disease. Ulcers were typically narrow and some extended transmurally
with fistula formation.
Fig. 2. A section of lymph node obtained at biopsy showing multiple epithelioid granulomas composed of histiocytes.
supporting a diagnosis of sarcoidosis. Apart from inter-
mittent knee arthritis she had no extrapulmonary fea-
tures. She did not receive treatment for sarcoidosis and
her lymphadenopathy spontaneously regressed. Both her
granulomatous disorders are currently quiescent without
therapy.
3. Discussion
Colitis in CF can occur for a number of different
reasons including Crohn’s disease, pseudomembranous
colitis and fibrosing colonopathy. Colitis due to Crohn’s
disease has a predilection for the ileocolic region,
possibly due to CF-related defects in the enterohepatic
circulation w1x. The case for a pathogenic link between
CF and Crohn’s disease is strong given that its preva-
lence in CF is approximately 17 times higher than in
controls. There appears to be an association between
Crohn’s colitis, meconium ileus at birth and the delta F
508 mutation w1x. In a series of 12 CF patients with
Crohn’s disease, 50–67% also had DIOS, 33% had
arthritis, 75% had ileocolic involvement with fistula
formation and 83% required surgical treatment w1x.
Active Crohn’s disease is likely to remain active during
pregnancy. Likewise, as in our patient, quiescent disease
should remain quiescent w2x. Our case highlights the
fact that although DIOS is the most common cause of
abdominal pain with a mass in CF, other possibilities
including appendicitis, Crohn’s disease, or colonic stric-
tures need consideration if symptoms persist.
There have been very few cases of pulmonary sar-
coidosis described in CF w3x. However, there have been
a number of cases of non-pulmonary sarcoid reported
including granulomatous arthritis, erythema nodosum
and iritis w3,4x. Diagnosis of pulmonary sarcoid in CF
is challenging given that most adult patients already
have extensive lung disease. There are also important
differential diagnoses to consider. Our patient had a
history of treatment with corticosteroids, a pregnancy
and the development of diabetes, all of which predis-
posed her to fungal or mycobacterial infection. We
carefully excluded bacterial, fungal and atypical and
typical mycobacterial infection as causes of her granu-
lomatous hilar adenopathy. Although studies from Eur-
opean and North American centers quote the prevalence
of non-tuberculous mycobacteria in patients with CF as
13% w5x, prevalence in Australia is much lower at 0.3%
w6x. Similarly Histoplasma capsulatum, a common cause
of granulomatous lung disease in the US, is rarely found
in Australia w7x. Our patient’s mediastinal adenopathy
occurred prior to infection with B. cepacia and regressed
spontaneously despite persistent B. cepacia colonization.
The necrotizing granulomas typically seen with B. cepa-
cia w8x were not present and B. cepacia was not isolated
from the nodal specimens. An elevated serum ACE level
has a specificity of 90% for sarcoidosis w9x, strongly
supporting our patient’s diagnosis of pulmonary sarcoid.
Although Crohn’s disease can manifest as granuloma-
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tous pulmonary disease, neither mediastinal adenopathy
nor elevated ACE levels are typically seen w9x. Sarcoid-
osis has no known adverse effects on pregnancy, but it
typically worsens within 6 months of parturition w10x.
In keeping with this, our patient’s hilar adenopathy first
became prominent post partum.
Cystic fibrosis aside, there have only been a few
cases of co-existing sarcoidosis and Crohn’s disease
described in the literature w11x. As in our patient, in
most cases the Crohn’s disease has preceded the sar-
coidosis, in one case by up to 16 years w11x. Certain
pathological and immunological similarities between
Crohn’s disease and sarcoidosis such as similar CD4y
CD8 lymphocyte ratios on bronchoalveolar lavage and
abnormalities of intestinal permeability suggest a possi-
ble etiological link w12x. Both conditions are character-
ized by higher than normal IgG antibodies to
mycobacterial species w13x.
There may also be a pathogenic link between the two
granulomatous conditions and CF. The most likely path-
ogenic mechanism is an altered immune response in CF
secondary to chronic infection w3x. Chronic immune
stimulation in CF leads to hyperimmunoglobulinemia
and circulating immune complexes similar to those seen
in sarcoidosis. Progressive tissue damage and defective
bronchial mucosal surfaces may potentiate antigen pres-
entation in CF w3x. In the presence of excessive antibody,
large antigen–antibody complexes may form that are
resistant to digestion by phagocytic cells. These com-
plexes are known to cause granulomas in animals w14x.
4. Conclusion
This is a unique case of a patient with two different
granulomatous disorders in addition to CF. Her sarcoid-
osis spontaneously regressed and her Crohn’s disease,
despite the need for surgery, subsequently remained
stable and quiescent. In other ways, however, she typi-
fied the resilient older CF patient. She had multisystem
involvement and major complications, including P. aeru-
ginosa colonization, asymptomatic carriage of B. cepa-
cia, and diabetes. Despite all this she was married,
caring for her child, and coping well with a good quality
of life.
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